Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer. Acun T, Senses KM. Breast Cancer 2020 Jan 4. pii: 10.1007/s12282-019-01042.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Acun T, Senses KM. Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer. Breast Cancer 2020 Jan 4. pii: 10.1007/s12282-019-01042.
PMID: 31902119